N/A
Completed N=10
Response Inhibition in Tourette Syndrome
Source: ClinicalTrials.gov NCT03628703 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Stop Signal Reaction Time (SSRT) — 249; 245 milliseconds — p=0.49
Summary
Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Stop Signal Reaction Time (SSRT) |
249; 245 | 0.49 |
Eligibility Criteria
Inclusion Criteria
- Tourette Syndrome
Exclusion Criteria
- Autism spectrum disorder
- Mood disorder
- Epilepsy
- Implanted medical device (e.g. pacemaker, shunt, pumps)
Data sourced from ClinicalTrials.gov (NCT03628703). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.